LAURA JOHNSON: Open Payments
NPI 1417948530 · DRIPPING SPRINGS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,508 in 93 payments from 15 companies in 2025. Trend: 2023 $1,461 · 2024 $1,985 · 2025 $2,508
Food & beverage: $1,558Consulting: $861Education: $89
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $1,126 |
| ABBVIE INC. | 21 | $334 |
| Janssen Biotech, Inc. | 17 | $298 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $188 |
| Celltrion USA Inc. | 12 | $157 |
| PFIZER INC. | 5 | $85 |
| Aimmune Therapeutics, Inc. | 3 | $59 |
| Novo Nordisk Inc | 2 | $49 |
| Ardelyx, Inc. | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
Products named: SARCLISA, TREMFYA, DUPIXENT, XIFAXAN, VEGZELMA, LINZESS, RINVOQ, VELSIPITY.
Industry payments across TX — which companies pay providers there.
